InsiderTrades.com logo
We recommended Nvidia in 2016, now we’re recommending this…
From Porter & Company   |   Ad
The AI boom is just getting started. And the real wealth has still to be made…
You must read this new presentation from Porter Stansberry.

NSPR Insider Trading

Insider Ownership Percentage: 29.72%
Insider Buying (Last 12 Months): $126,500.00
Insider Selling (Last 12 Months): $0.00

InspireMD Insider Trading History Chart

This chart shows the insider buying and selling history at InspireMD by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

InspireMD Share Price & Price History

Current Price: $3.39
Price Change: ▲ Price Increase of +0.41 (13.76%)
As of 07/26/2024 01:00 AM ET

This chart shows the closing price history over time for NSPR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
We recommended Nvidia in 2016, now we’re recommending this…
From Porter & Company   |   Ad
The AI boom is just getting started. And the real wealth has still to be made…
You must read this new presentation from Porter Stansberry.

InspireMD Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/30/2023Gary S RoubinDirectorBuy50,000$2.53$126,500.00438,902View SEC Filing Icon  
5/12/2023Paul StukaDirectorBuy175,000$1.63$285,250.00248,534View SEC Filing Icon  
See Full Table
Collapse of the Petrodollar
From Colonial Metals   |   Ad
The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar.
In answer to this issue, we have released a Special Report to the public.

SEC Filings (Institutional Ownership Changes) for InspireMD (NYSE:NSPR)

44.78% of InspireMD stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at NSPR by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

InspireMD Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
7/12/2024Rosalind Advisors Inc.2,513,641$6.27M4.6%+266.4%10.083%Search for SEC Filing on Google Icon
4/26/2024Mesirow Financial Investment Management Inc.30,000$71K0.0%N/A0.128%Search for SEC Filing on Google Icon
4/25/2024Rosalind Advisors Inc.686,062$1.63M1.5%-25.8%2.932%Search for SEC Filing on Google Icon
2/7/2024McKinley Carter Wealth Services Inc.10,000$28K0.0%N/A0.046%Search for SEC Filing on Google Icon
10/20/2023Avestar Capital LLC20,000$65K0.0%N/A0.094%Search for SEC Filing on Google Icon
8/14/2023Pura Vida Investments LLC55,680$0.14M0.0%N/A0.263%Search for SEC Filing on Google Icon
8/11/2023Velan Capital Investment Management LP904,029$2.27M2.1%N/A4.266%Search for SEC Filing on Google Icon
8/8/2023Nottingham Advisors Inc.25,000$63K0.0%N/A0.118%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
InspireMD logo
InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.
Read More on InspireMD

Today's Range

Now: $3.39
Low: $2.96
High: $3.42

50 Day Range

MA: $2.55
Low: $2.28
High: $3.39

52 Week Range

Now: $3.39
Low: $1.81
High: $3.85

Volume

100,953 shs

Average Volume

26,636 shs

Market Capitalization

$84.51 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.96

Who are the company insiders with the largest holdings of InspireMD?

InspireMD's top insider investors include:
  1. Gary S Roubin (Director)
  2. Paul Stuka (Director)
Learn More about top insider investors at InspireMD.

Who are the major institutional investors of InspireMD?

InspireMD's top institutional investors include:
  1. Rosalind Advisors Inc. — 10.08%
Learn More about top institutional investors of InspireMD stock.

Which institutional investors are buying InspireMD stock?

During the previous quarter, NSPR stock was purchased by institutional investors including:
  1. Rosalind Advisors Inc.
Within the last year, these company insiders have bought InspireMD stock:
  1. Gary S Roubin (Director)
  2. Paul Stuka (Director)
Learn More investors buying InspireMD stock.
We recommended Nvidia in 2016, now we’re recommending this…
From Porter & Company   |   Ad
The AI boom is just getting started. And the real wealth has still to be made…
You must read this new presentation from Porter Stansberry.